Targeting prostate cancer by new bispecific monocyte engager directed to prostate-specific membrane antigen
G. Das, J. Ptacek, B. Havlinova, J. Nedvedova, C. Barinka, Z. Novakova
This paper describes the design and characterization of a bispecific monocyte engager targeting PSMA for prostate cancer immunotherapy, showing effective activation of monocytes and tumor cell elimination.
bioRxiv · Jul 5, 2024Bioengineering